Oxurion trades 0 percent unchanged on Tuesday 27th of OctoberOxurion NV stock flat at €0, down 55.6% last month, yet its eye‑care pipeline – JETREA, THR‑317 – fuels investor interest amid biopharma growth.OXURION NVBelgium Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Elliot Mercer 27/10/2026, 02:37 2 minutes to read
